Proton magnetic resonance spectroscopy of the brain: Indications for the diagnosis and follow-up of HIV-related encephalopathy in adults;Spectroscopie de resonance magnetique cerebrale du proton: Indications dans le diagnostic et le suivi de l'encephalopathie liee au VIH chez l'adulte

Presse Medicale

Volumn 27, Issue 27, 1998, Pages 1398-1405

  Vion Dury, J ^a   Salvan, A M ^a   Confort Gouny, S ^a   Cozzone, P J ^a  

^a University of Aix Marseille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DISEASE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; ARTICLE; BRAIN; ENERGY METABOLISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; DRUG DERIVATIVE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

AIDS DEMENTIA COMPLEX; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOCREATINE; REFERENCE VALUES;

EID: 0032547504     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Trotot PM, Gray F. Diagnostic imaging. Contribution in the early stages of HIV infection of the brain. Neuroimaging of AIDS. Neuroimag Clin North Am 1997 ; 7:243-60.
2. McArthur JC. HIV dementia: 10 years on. J Neurovirol 1996 ; 2:8.
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988 ; 239:386-92.
4. Peluso R, Haase A, Strowing L, Edwards M, Ventura P. A trojan horse mechanism for the spread of visna virus in monocytes. Virology 1985 ; 147:231-6.
5. Epstein LG, Gendelman HE. Human immunodeficiency virus type I infection of the nervous system: pathogenetic mechanisms. Ann Neurol 1993 ; 33:429-36.
6. Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A et al. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity. Trends Neurosci 1996 ; 19:109-14.
7. Gray F, Lescs MC. HIV-related demyelinating disease. Eur J Med 1993 ; 2:89-96.
8. Confort-Gouny S, Vion-Dury J, Cozzone PJ. Méthodes de localisation du signal de RMN in vivo. Vers une approche métabolique des pathologies. J Radiol (Paris), 1992 ; 73(1):13-21.
9. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact in neurology of in vivo analysis of the brain metabolism by magnetic resonance spectroscopy? J Neurol 1994 ; 241:354-71.
10. Menon DK, Baudouin CJ, Tomlinson D, Hoyle C. (1990) Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr 1990 ; 14:882-5.
11. Chong WK, Sweeney B, Wilkinson ID et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993 ; 188:119-24.
12. Meyerhoff DJ, MacKay S, Bachman L et al. Reduced brain N-acetyl-aspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993 ; 43:509-15.
13. Vion-Dury J, Confort-Gouny S, Nicoli F et al. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies CR Acad Sci Paris, Sciences de la vie/Life sciences 1994 ; 317:833-40.
14. Laubenberger J, Häussinger D, Bayer S et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996 ; 199:805-10.
15. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ. Cerebral metabolic alterations in HIV-related encephalopathy detected by brain proton MR spectroscopy: comparison between sequences using short and long echo times. Invest Radiol 1997 ; 32:485-95.
16. Paley M, Cozzone PJ, Alonso J et al. A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Human Retrovir 1996 ; 12:213-22.
17. Brew BJ. The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Curr Opin Neurol 1994 ; 209-16.
18. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ. Brain proton MR spectroscopy in HIV-related encephalopathies. Identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Human Retrovir 1997 ; 13:1055-66.
19. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ. Reversal of brain metabolic alteration with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet 1995 ; 345:60-1.
20. Chinn RJS, Wilkinson ID, Hall-Craggs MA et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995 ; 197:649-54.
21. Swindells S, McConnel JR, McComb R, and Gendelman HE. Utility of cerebral proton magnetic resonance spectroscopy in differential diagnosis of HIV-related dementia. J Neurovirol 1995 ; 1:2868-74.
22. Chang L, Ernst T, Tomatore C et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997 ; 48:836-45.
23. Wilkinson ID, Miller RF, Paley M et al. Cerebral proton magnetic resonance spectroscopy in cytomegalovirus encephalitis and HIV-leukoencephalopathy/ encephalitis. AIDS 1996; 10(12):1443-4.